Bristol-Myers Squibb to acquire Mirati in $5.8 billion deal

United States News News

Bristol-Myers Squibb to acquire Mirati in $5.8 billion deal
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 97%

Bristol-Myers Squibb (BMY.N) on Sunday said it will acquire Mirati Therapeutics (MRTX.O) in a transaction that values the cancer drugmaker at up to $5.8 billion.

Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File PhotoMirati stockholders will receive one non-tradeable contingent value right for each Mirati share held, potentially worth $12.00 per share in cash, representing an additional $1 billion of value opportunity, the company added.

The transaction will help grow Bristol-Myers’s oncology franchise with the addition of Mirati's lung cancer drug Krazati. Bristol is buying Mirati at a time when the shares are considerably cheaper than they were. Mirati's shares touched a 52-week high of $101.3 apiece on Nov. 28 and are now trading at $60.2.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion deal
Read more »

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionBristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionDeal expands pharmaceutical company’s portfolio of cancer drugs
Read more »

Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billionBristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billionMirati develops commercial-stage oncology therapies, and through the deal, Bristol Myers Squibb will add lung-cancer medicine Krazati, among others, to its...
Read more »

Elyse Myers Is Sharing Her Postpartum Essentials, & It’s Honestly So HelpfulElyse Myers Is Sharing Her Postpartum Essentials, & It’s Honestly So HelpfulFrom adult diapers to a mini-fridge, Elyse Myers reveals the products she can't live without since giving birth to her second child.
Read more »

Lucrative Bristol Bay red king crab fishery to reopen after 2-year closureLucrative Bristol Bay red king crab fishery to reopen after 2-year closureThe Alaska Department of Fish and Game announced Friday morning that the lucrative crab fishery will open Oct. 15.
Read more »

Something went wrong. Please disable your blocker on Collider.Something went wrong. Please disable your blocker on Collider.Michael Myers and Pinhead could have teamed up to raise hell together!
Read more »



Render Time: 2025-02-22 21:56:09